Sangamo Therapeutics Stock Forecast
| Recent Sangamo Therapeutics Stock Price | Sangamo Therapeutics Stock Forecast Price | |
| $5.20 |  +135.19% |
$12.23 |
| Recent Sangamo Therapeutics Analyst Ratings Breakdown | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 5 | 5 | 5 | 5 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 2 | 2 | 2 | 2 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.57 | 1.57 | 1.57 | 1.57 |
The presented Sangamo Therapeutics stock forecast (traded under symbol SGMO), for forward-twelve-months price target as shown at the top of this page, gives you the average Sangamo Therapeutics stock forecast for forward target price for symbol SGMO, across the 6 analysts covering Sangamo Therapeutics (SGMO), as reported in data provided by Zacks Investment Research via Quandl.com.
Investors should also take note that the median Sangamo Therapeutics stock forecast price target (i.e. representing the middle ground number where half of analysts had a higher Sangamo Therapeutics stock forecast and half had a lower Sangamo Therapeutics stock forecast) was $10.0 as of 2022-08-08 (which is a different mathematical metric versus taking the average or mean), while the
highest Sangamo Therapeutics stock forecast in the analyst group was $25.0, and the lowest Sangamo Therapeutics stock forecast in the analyst group was
$4.4, with a standard deviation of $8.251. Get the latest Zacks research report on SGMO — FREE
Top Analyst Picks of the Dow
The Top 20 Largest U.S. Stocks By Market Cap
|
|||||||||||||||||||||
|
|
|
 Free SGMO Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
 
|
Buy (3.43 out of 4) 44th percentile
(ranked lower than approx. 56% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
|
|
